INCY:NASDAQ
Incyte Corp
$122.19
arrow_upward
+0.59%(+0.72) 1D
$122.31
arrow_upward
+0.10% (+0.12)bedtimeAfter hours
Closed: Sep 14, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$122.48
High
$123.34
Low
$121.28
Mkt. cap
24.77B
Avg. vol.
1.35M
Volume
1.46M
P/E ratio
15.57
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
Open
$122.48
High
$123.34
Low
$121.28
Mkt. cap
24.77B
Avg. vol.
1.35M
Volume
1.46M
P/E ratio
15.57
52-wk high
$132.58
52-wk low
$81.09
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
Zacks
·
4 hours ago
INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?
Yahoo Finance
·
4 hours ago
INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?
ad-hoc-news.de
·
13 hours ago
Incyte stock holds firm as quarterly revenue jumps 37.7 percent
StockStory
·
1 day ago
Incyte (INCY): 3 Reasons We Love This Stock
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com